BRIGHT MINDS BIOSCIENCES INC (DRUG) Institutional Ownership and Insiders Activity

BRIGHT MINDS BIOSCIENCES INC (DRUG) is widely held by institutional investors, with 98 firms reporting positions valued at approximately $651.91M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Janus Henderson Group Plc is the largest disclosed holder, reporting approximately $93.52M in DRUG holdings in its latest filing.